New London Hospital Critical Access Hospital (Medicare Certified) Location: 273 County Road, New London, New Hampshire 03257 Ratings: Phone: (603) 526-2911 |
Memorial Hospital, The Critical Access Hospital (Medicare Certified) Location: 3073 White Mountain Highway, North Conway, New Hampshire 03860 Ratings: Phone: (603) 356-5461 |
Monadnock Community Hospital Critical Access Hospital (Medicare Certified) Location: 452 Old Street Road, Peterborough, New Hampshire 03458 Ratings: Phone: (603) 924-7191 |
Speare Memorial Hospital Critical Access Hospital (Medicare Certified) Location: 16 Hospital Road, Plymouth, New Hampshire 03264 Ratings: Phone: (603) 536-1120 |
Portsmouth Regional Hospital Acute Care Hospital (Medicare Certified) Location: 333 Borthwick Ave, Portsmouth, New Hampshire 03801 Ratings: Phone: (603) 436-5110 |
Frisbie Memorial Hospital Acute Care Hospital (Medicare Certified) Location: 11 Whitehall Road, Rochester, New Hampshire 03867 Ratings: Phone: (603) 332-5211 |
Huggins Hospital Critical Access Hospital (Medicare Certified) Location: 240 South Main Street, Wolfeboro, New Hampshire 03894 Ratings: Phone: (603) 569-7500 |
Cottage Hospital Critical Access Hospital (Medicare Certified) Location: 90 Swiftwater Rd, Woodsville, New Hampshire 03785 Ratings: Phone: (603) 747-9000 |
News Archive
Senesco Technologies, Inc. reported today that it was informed on July 26th that the U.S. Food and Drug Administration has granted orphan-drug designation for the company's lead drug candidate SNS01-T for treatment of both mantle cell lymphoma and diffuse large B-cell lymphoma.
Today the Alliance for Patient Access released a new white board video, "A Prescription for Reducing Opioid Abuse." The video, released to coincide with National Pain Awareness Month, highlights new technology and innovative pill formulations that deter individuals from abusing opioids.
Are you allergic to Valentine's Day? More than 50 million Americans might be, according to the Asthma and Allergy Foundation of America. Choosing the wrong meal or gift could turn your romantic night into an unforgettable one — in the emergency room.
Merz Pharmaceuticals today announced that the United States Food and Drug Administration has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.
› Verified 5 days ago